Table 1.
Clinical details for study patients at time of SBRT, N = 12
| Variable | No. | % |
| ECOG status | ||
| 0 | 6 | 50 |
| 1 | 3 | 25 |
| 2 | 3 | 25 |
| Sex | ||
| Male | 11 | 91.66 |
| Female | 1 | 8.33 |
| HCC lesions treated | ||
| 1 | 7 | 58.33 |
| 2 | 5 | 41.66 |
| Milan Criteria | ||
| within | 9 | 75 |
| outside | 3 | 25 |
| Cause of Cirrhosis | ||
| Hepatitis C | 8 | 66.66 |
| NASH | 2 | 16.66 |
| Alcoholic Liver disease | 1 | 8.33 |
| Iron Overload | 1 | 8.33 |
| Child Pugh Score | ||
| 8 | 5 | 41.66 |
| 9 | 2 | 16.66 |
| 10 | 4 | 33.33 |
| 11 | 1 | 8.33 |
| MELD-Na score | ||
| <10 | 1 | 8.33 |
| 10-19 | 10 | 83.33 |
| 20-29 | 1 | 8.33 |
| >30 | 0 | 0 |
| Previous TACE X1 | ||
| No | 10 | 83.33 |
| Yes | 2 | 16.66 |
*
Abbreviations: ECOG, Eastern Cooperative Oncology Group; NASH, Non-alcoholic Steatohepatitis; MELD-Na, Model for end-stage liver disease; TACE, Transarterial chemoembolization.